Hookipa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary

Hookipa Pharma

10/08/2023 16:12

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 22 cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 21
cents per share.
    * Revenue fell 2.4% to $2.68 million from a year ago;
analysts
expected $4.87 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 22 cents​.
    * The mean earnings estimate of analysts had risen by
about 11.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * HOOKIPA Pharma Inc shares had fallen by 16.2% this
quarter and
lost 9.0% so far this year.
    * The company reported a quarterly loss of $18.02 million.
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 03:12 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.21          -0.22          Missed
 Mar. 31 2023      -0.23          -0.27          Missed
 Dec. 31 2022      -0.21          -0.17          Beat
 Sep. 30 2022      -0.28          -0.25          Beat